PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 33 filers reported holding PDL BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $329,000 | +45.6% | 104,362 | +34.3% | 0.00% | – |
| Q2 2020 | $226,000 | -17.8% | 77,713 | -20.4% | 0.00% | – |
| Q1 2020 | $275,000 | -68.4% | 97,647 | -63.7% | 0.00% | -100.0% |
| Q4 2019 | $870,000 | +145.8% | 268,646 | +63.3% | 0.00% | – |
| Q3 2019 | $354,000 | -22.4% | 164,514 | +12.6% | 0.00% | – |
| Q2 2019 | $456,000 | +74.0% | 146,089 | +106.3% | 0.00% | – |
| Q1 2019 | $262,000 | +6.1% | 70,829 | -17.4% | 0.00% | – |
| Q4 2018 | $247,000 | -93.6% | 85,792 | -94.2% | 0.00% | -100.0% |
| Q3 2018 | $3,870,000 | +11.9% | 1,472,119 | -0.5% | 0.00% | 0.0% |
| Q2 2018 | $3,458,000 | +62.0% | 1,479,096 | +103.6% | 0.00% | 0.0% |
| Q1 2018 | $2,134,000 | +16.4% | 726,505 | +8.5% | 0.00% | 0.0% |
| Q4 2017 | $1,834,000 | -46.3% | 669,820 | -33.6% | 0.00% | -50.0% |
| Q3 2017 | $3,418,000 | -19.9% | 1,008,977 | -41.6% | 0.00% | -33.3% |
| Q2 2017 | $4,266,000 | +117.9% | 1,727,608 | +100.0% | 0.00% | +200.0% |
| Q1 2017 | $1,958,000 | +267.4% | 863,617 | +243.0% | 0.00% | – |
| Q4 2016 | $533,000 | -83.2% | 251,786 | -73.4% | 0.00% | -100.0% |
| Q3 2016 | $3,170,000 | +139.4% | 946,385 | +124.1% | 0.00% | +100.0% |
| Q2 2016 | $1,324,000 | -73.1% | 422,224 | -71.5% | 0.00% | -75.0% |
| Q1 2016 | $4,923,000 | +120.1% | 1,479,291 | +133.9% | 0.00% | +100.0% |
| Q4 2015 | $2,237,000 | -53.8% | 632,372 | -34.3% | 0.00% | -50.0% |
| Q3 2015 | $4,837,000 | -55.4% | 962,004 | -43.0% | 0.00% | -42.9% |
| Q2 2015 | $10,853,000 | -21.2% | 1,688,237 | -13.8% | 0.01% | -22.2% |
| Q1 2015 | $13,777,000 | +12.3% | 1,958,638 | +23.1% | 0.01% | +12.5% |
| Q4 2014 | $12,264,000 | -7.5% | 1,590,805 | -10.4% | 0.01% | 0.0% |
| Q3 2014 | $13,254,000 | +32.8% | 1,774,511 | +72.0% | 0.01% | +14.3% |
| Q2 2014 | $9,984,000 | -14.9% | 1,031,584 | -26.9% | 0.01% | -12.5% |
| Q1 2014 | $11,727,000 | +16.3% | 1,411,405 | +18.1% | 0.01% | +14.3% |
| Q4 2013 | $10,086,000 | +16.1% | 1,195,249 | +9.6% | 0.01% | +16.7% |
| Q3 2013 | $8,690,000 | – | 1,090,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Silver Point Capital L.P. | 23,783,273 | $58,745,000 | 6.82% |
| Park West Asset Management LLC | 14,397,212 | $35,561,000 | 0.74% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 633,700 | $1,565,000 | 0.24% |
| JBF Capital, Inc. | 543,990 | $1,344,000 | 0.22% |
| Context Capital Management, LLC | 465,172 | $1,149,000 | 0.16% |
| Bellecapital International Ltd. | 108,025 | $267,000 | 0.09% |
| FNY Investment Advisers, LLC | 100,000 | $247,000 | 0.07% |
| WINTON GROUP Ltd | 291,360 | $720,000 | 0.05% |
| Freedom Investment Management, Inc. | 54,735 | $135,000 | 0.02% |
| HANCOCK WHITNEY CORP | 187,757 | $464,000 | 0.02% |